Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DOCU | U |
|---|---|---|
| Price | $69.36 | $43.15 |
| Change today | ▲ 3.29% | ▲ 5.41% |
| Market cap | $12.96B | $18.99B |
| Return, 3 months | +50.7% | +42.9% |
| Return, year to date | +1.4% | -2.3% |
| Return, 1 year | +0.6% | +12.7% |
| P/E (TTM) | 42.3 | -31.7 |
| P/B | 7.5 | 6.3 |
| P/E percentile vs own 5y | 77th | 25th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +9.4% | +23.9% |
| Net profit growth (YoY) | +23.4% | +78.9% |
| Gross margin | 79.5% | 64.9% |
| Operating margin | 12.0% | -30.4% |
| Net margin | 9.8% | -29.0% |
| Return on equity | 17.8% | -18.9% |
| Analyst target vs. price | +3.3% | +12.9% |
| Analyst buy share | 20% | 88% |
| RSI (14) | 53 | 47 |
| 30-day volatility | 44.2% | 37.8% |
| Max drawdown, 1 year | -50.9% | -65.4% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
